Literature DB >> 344799

Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).

M Sugimoto, R N Germain, L Chedid, B Benacerraf.   

Abstract

The adjuvant effect of a synthetic peptidoglycan, muramyl dipeptide (N-acetyl muramyl-L-alanyl-D-isoglutamine, MDP), was studied by using the anti-Tnp PFC and hemagglutinin responses of BALB/c mice to hapten-carrier conjugates. Administration of Tnp-OVA and MDP in saline to mice, followed 2 weeks later by a boost of Tnp-OVA in saline, led to significantly higher IgM and IgG anti-Tnp PFC and total anti-Tnp-hemagglutinin responses than those obtained in mice not treated with MDP in the initial immunization. A similar adjuvant effect by MDP on anti-hapten PFC responses was seen if mice were primed with KLH together with MDP and challenged with Tnp-KLH 2 weeks later. This apparent effect on carrier priming for helper function was confirmed and quantitated by double adoptive transfer experiments with graded numbers of spleen cells from KLH +/- MDP-primed mice and a fixed number of hapten-primed spleen cells from syngeneic Tnp-OVA immunized animals. These data suggest that at least one mode of action of the synthetic adjuvant MDP is via the enhanced stimulation of the helper T cell function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 344799

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Cognate T-cell help in the induction of IgA responses in vivo.

Authors:  M L Dunkley; A J Husband; B J Underdown
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

2.  Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.

Authors:  G M Bahr; E C Darcissac; N Castéran; C Amiel; C Cocude; M J Truong; J Dewulf; A Capron; Y Mouton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium.

Authors:  D Archambault; G Morin
Journal:  Can Vet J       Date:  1988-01       Impact factor: 1.008

4.  NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy.

Authors:  Mirjam Schenk; Stephan R Krutzik; Peter A Sieling; Delphine J Lee; Rosane M B Teles; Maria Teresa Ochoa; Evangelia Komisopoulou; Euzenir N Sarno; Thomas H Rea; Thomas G Graeber; Soohyun Kim; Genhong Cheng; Robert L Modlin
Journal:  Nat Med       Date:  2012-03-25       Impact factor: 53.440

5.  New age adjuvants and delivery systems for subunit vaccines.

Authors:  S Kurella; M Manocha; L Sabhnani; B Thomas; D N Rao
Journal:  Indian J Clin Biochem       Date:  2000-08

6.  Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation.

Authors:  J W Mannhalter; H O Neychev; G J Zlabinger; R Ahmad; M M Eibl
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

7.  Relationships between adjuvant, immunosuppressive, and mitogenic activities of staphylococcal peptidoglycan.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

8.  Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.

Authors:  M Parant; F Parant; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.

Authors:  I Löwy; C Leclerc; L Chedid
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

10.  Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog.

Authors:  H F Acevedo; R B Raikow; H O Acevedo; T F Delgado; M Pardo
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.